-
BioCryst Announces $325 Million of Funding from Royalty Pharma and Athyrium Capital Management
Post on 12/7/20
-
Syneos Health Prices of Secondary Offering of Common Stock
Post on 12/2/20
-
Syneos Health Announces Secondary Offering of Common Stock
Post on 12/1/20
-
G1 Therapeutics: Depressed Price Before Catalyst, No Apparent Reason
Post on 11/30/20
-
Syneos Health Closes of $600.0 Million of Senior Notes
Post on 11/25/20
-
Syneos Health Closes Offering of $600M of Senior Notes
Post on 11/24/20
-
vTv Therapeutics Announces Common Stock Purchase Agreement for up to $47M with Lincoln Park Capital
Post on 11/24/20
-
Syneos Health Announces Upsizing and Pricing of Offering of $600M of Senior Notes
Post on 11/18/20
-
Syneos Health Offers Senior Notes
Post on 11/18/20
-
Fennec Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update
Post on 11/16/20
-
Milestone Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical and Corporate Update
Post on 11/13/20
-
Precision BioSciences Reports Third Quarter 2020 Financial Results and Provides Business Update
Post on 11/10/20
-
FDA Grants Emergency Use Authorization for Proprietary Mask from HanesBrands
Post on 11/6/20
-
Chimerix Misses Q3 Estimates by a Penny
Post on 11/5/20
-
BioCryst Reports Third Quarter 2020 Financial Results
Post on 11/5/20
-
BioDelivery Sciences Reports Strong Q3 2020 Results
Post on 11/5/20
-
BioDelivery Sciences Announces $25 Million Share Repurchase Program
Post on 11/5/20
-
BioDelivery Sciences Announces $25 Million Share Repurchase Program
Post on 11/4/20
-
G1 Therapeutics Provides Financial Update
Post on 11/4/20
-
Novan Receives Approval to Transfer to Nasdaq Capital Market
Post on 11/4/20
-
Novan Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Post on 10/30/20
-
Syneos Health Reports Third Quarter 2020 Results
Post on 10/29/20
-
LabCorp Announces 2020 Third Quarter Results
Post on 10/27/20
-
Aerie Pharmaceuticals to Announce Third Quarter 2020 Financial Results
Post on 10/27/20
-
Bayer Acquires Asklepios BioPharmaceutical
Post on 10/26/20
Charlotte Raleigh
